Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Jablons

Showing results (111-120 of 197) with videos related to

Pageof 20
Sort By:
Lung Cancer (Amsterdam, Netherlands)|July 16, 2014
The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesotheliomaEtienne Giroux Leprieur, Tomomi Hirata, Minli Mo, et al.
International Journal of Oncology|April 29, 2016
Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratoriesPedro Mendez, Jennifer Dang, James Wansoo Kim, et al.
Clinical Lung Cancer|September 21, 2021
Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non-Squamous Non-Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant ChemotherapyGavitt A Woodard, Johannes R Kratz, Greg Haro, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 20, 2004
Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PETZhen J Wang, Gautham P Reddy, Michael B Gotway, et al.
Scientific Reports|September 29, 2016
FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoidHio Chung Kang, Jong In Kim, Hee Kyung Chang, et al.
Experimental and Therapeutic Medicine|May 31, 2018
Transfer of multiple loci of donor's genes to induce recipient tolerance in organ transplantationTong Li, Wenqian Zhang, Qing Xu, et al.
Oncotarget|March 5, 2015
Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cellsBin You, Yi-Lin Yang, Zhidong Xu, et al.
Clinical Lung Cancer|December 17, 2018
Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping MutationJulia K Rotow, Gavitt A Woodard, Anatoly Urisman, et al.
Anticancer Research|January 30, 2008
Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growthKazutsugu Uematsu, Nobuhiko Seki, Takashi Seto, et al.
BMC Cancer|May 26, 2005
Efficacy of Wnt-1 monoclonal antibody in sarcoma cellsIwao Mikami, Liang You, Biao He, et al.
Pageof 20

Showing results (111-120 of 197) with videos related to

Sort By:
Pageof 20
Lung Cancer (Amsterdam, Netherlands)|July 16, 2014
The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesotheliomaEtienne Giroux Leprieur, Tomomi Hirata, Minli Mo, et al.
International Journal of Oncology|April 29, 2016
Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratoriesPedro Mendez, Jennifer Dang, James Wansoo Kim, et al.
Clinical Lung Cancer|September 21, 2021
Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non-Squamous Non-Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant ChemotherapyGavitt A Woodard, Johannes R Kratz, Greg Haro, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 20, 2004
Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PETZhen J Wang, Gautham P Reddy, Michael B Gotway, et al.
Scientific Reports|September 29, 2016
FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoidHio Chung Kang, Jong In Kim, Hee Kyung Chang, et al.
Experimental and Therapeutic Medicine|May 31, 2018
Transfer of multiple loci of donor's genes to induce recipient tolerance in organ transplantationTong Li, Wenqian Zhang, Qing Xu, et al.
Oncotarget|March 5, 2015
Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cellsBin You, Yi-Lin Yang, Zhidong Xu, et al.
Clinical Lung Cancer|December 17, 2018
Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping MutationJulia K Rotow, Gavitt A Woodard, Anatoly Urisman, et al.
Anticancer Research|January 30, 2008
Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growthKazutsugu Uematsu, Nobuhiko Seki, Takashi Seto, et al.
BMC Cancer|May 26, 2005
Efficacy of Wnt-1 monoclonal antibody in sarcoma cellsIwao Mikami, Liang You, Biao He, et al.
Pageof 20